Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
45 Years to 60 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Generally health postmenopausal women 45 to 60 years of age, inclusive
No hormone replacement therapy within the 90 days immediately prior to the screening evaluation.
Known or suspect estrogen-dependent neoplasia
Known hypersensitivity to estrogens, progestins, or other ingredients of Totelle
Use of any estrogen, progestin, androgen containing medications or tibolone within 12 weeks before screening.